Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lenacapavir (GS-6207) is a potent capsid-targeting inhibitor of HIV replication. Lenacapavir shows anti-HIV activity with an EC50 of 100 pM in MT-4 cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 333.00 | |
5 mg | In stock | $ 690.00 | |
10 mg | In stock | $ 1,130.00 | |
25 mg | In stock | $ 1,670.00 | |
50 mg | In stock | $ 2,250.00 | |
100 mg | In stock | $ 2,970.00 |
Description | Lenacapavir (GS-6207) is a potent capsid-targeting inhibitor of HIV replication. Lenacapavir shows anti-HIV activity with an EC50 of 100 pM in MT-4 cells. |
Targets&IC50 | Anti-HIV:100 pM (EC50), MT-4 cells:100 pM (EC50) |
In vitro | Lenacapavir displays a mean EC50 of 50 pM (20-160 pM) against 23 HIV-1 clinical isolates from different subtypes in peripheral blood mononuclear cells. Lenacapavir shows sub-nanomolar potency in target cells with EC50 of 23 pM, in a full-cycle assay with EC50 of 25 pM and in producer cells with EC50 of 439 pM[2]. |
Synonyms | GS-6207 |
Molecular Weight | 968.28 |
Formula | C39H32ClF10N7O5S2 |
CAS No. | 2189684-44-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 195 mg/mL (201.39 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lenacapavir 2189684-44-2 Microbiology/Virology Others Proteases/Proteasome HIV Protease MT-4 Inhibitor antiretroviral GS-6207 inhibit GS6207 capsid GS 6207 Human immunodeficiency virus HIV HIV-1 PBMCs inhibitor